Comparison between 18f-Dopa and 18f-Fet Pet/Ct in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and our Experience.

CONCLUSIONS: 18F-DOPA and 18F-FET PET/CT have a similar diagnostic accuracy in patients with recurrent HGG. However, 18F-DOPA PET/CT could be affected by inflammation conditions (false positive) that can alter the final results. Large comparative trials are warranted in order to better understand the utility of 18F-DOPA or 18F-FET PET/CT in patients with HGG.
PMID: 30644351 [PubMed - as supplied by publisher]

Source: Current Radiopharmaceuticals - January 16, 2019 Category: Radiology Tags: Curr Radiopharm Source Type: research